These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37646629)

  • 21. Exploring probiotic effector molecules and their mode of action in gut-immune interactions.
    Lee CG; Cha KH; Kim GC; Im SH; Kwon HK
    FEMS Microbiol Rev; 2023 Jul; 47(4):. PubMed ID: 37541953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The place of probiotics in human intestinal infections.
    Sullivan A; Nord CE
    Int J Antimicrob Agents; 2002 Nov; 20(5):313-9. PubMed ID: 12431865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of probiotics as an adjuvant agent in eradication of Helicobacter pylori infection and associated side effects.
    Goli YD; Moniri R
    Benef Microbes; 2016 Sep; 7(4):519-27. PubMed ID: 27241906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges.
    Wan MLY; Forsythe SJ; El-Nezami H
    Crit Rev Food Sci Nutr; 2019; 59(20):3320-3333. PubMed ID: 29993263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics (Lactobacillus plantarum HNU082) Supplementation Relieves Ulcerative Colitis by Affecting Intestinal Barrier Functions, Immunity-Related Gene Expression, Gut Microbiota, and Metabolic Pathways in Mice.
    Wu Y; Jha R; Li A; Liu H; Zhang Z; Zhang C; Zhai Q; Zhang J
    Microbiol Spectr; 2022 Dec; 10(6):e0165122. PubMed ID: 36321893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics as modulators of the gut flora.
    Fooks LJ; Gibson GR
    Br J Nutr; 2002 Sep; 88 Suppl 1():S39-49. PubMed ID: 12215180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Society of Sports Nutrition Position Stand: Probiotics.
    Jäger R; Mohr AE; Carpenter KC; Kerksick CM; Purpura M; Moussa A; Townsend JR; Lamprecht M; West NP; Black K; Gleeson M; Pyne DB; Wells SD; Arent SM; Smith-Ryan AE; Kreider RB; Campbell BI; Bannock L; Scheiman J; Wissent CJ; Pane M; Kalman DS; Pugh JN; Ter Haar JA; Antonio J
    J Int Soc Sports Nutr; 2019 Dec; 16(1):62. PubMed ID: 31864419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections.
    Keikha M; Karbalaei M
    BMC Gastroenterol; 2021 Oct; 21(1):388. PubMed ID: 34670526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics: progress toward novel therapies for intestinal diseases.
    Yan F; Polk DB
    Curr Opin Gastroenterol; 2010 Mar; 26(2):95-101. PubMed ID: 19952741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics in gastroenterology: indications and future perspectives.
    Goossens D; Jonkers D; Stobberingh E; van den Bogaard A; Russel M; Stockbrügger R
    Scand J Gastroenterol Suppl; 2003; (239):15-23. PubMed ID: 14743878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics as drugs against human gastrointestinal infections.
    Sanz Y; Nadal I; Sánchez E
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):148-56. PubMed ID: 18221171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotic-induced changes in the intestinal epithelium: implications in gastrointestinal disease.
    Ramakrishna BS
    Trop Gastroenterol; 2009; 30(2):76-85. PubMed ID: 19760989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotics to enhance anti-infective defences in the gastrointestinal tract.
    Gill HS
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):755-73. PubMed ID: 14507586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics: beneficial factors of the defence system.
    Antoine JM
    Proc Nutr Soc; 2010 Aug; 69(3):429-33. PubMed ID: 20540822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of probiotics and prebiotics with the gut microbiota.
    Ballan R; Battistini C; Xavier-Santos D; Saad SMI
    Prog Mol Biol Transl Sci; 2020; 171():265-300. PubMed ID: 32475525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of intestinal barrier properties by probiotics: role in reversing colitis.
    Resta-Lenert SC; Barrett KE
    Ann N Y Acad Sci; 2009 May; 1165():175-82. PubMed ID: 19538304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: Probiotics in gastrointestinal and liver diseases.
    Jonkers D; Stockbrügger R
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():133-48. PubMed ID: 18081657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.